EP 1326848 A1 20030716 - DIHYDROPYRIMIDINE DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
Title (en)
DIHYDROPYRIMIDINE DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
Title (de)
DIHYDROPYRIMIDINE DERIVATE ALS CYSTEINE PROTEASE INHIBITOREN
Title (fr)
DERIVES DE DIHYDROPYRIMIDINE UTILISES COMME INHIBITEURS DE CYSTEINE PROTEASE
Publication
Application
Priority
- IB 0100707 W 20010430
- US 24136000 P 20001019
Abstract (en)
[origin: WO0232879A1] Ditiydropyrimidine derivatives are disclosed, which can be used to inhibit cysteine protease activity.
IPC 1-7
C07D 239/22; C07D 401/04; C07D 407/04; C07D 409/12; A61K 31/505
IPC 8 full level
A61K 31/513 (2006.01); A61K 31/527 (2006.01); A61P 9/10 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 33/00 (2006.01); A61P 35/04 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 239/22 (2006.01); C07D 239/54 (2006.01); C07D 239/70 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 409/12 (2006.01)
CPC (source: EP US)
A61P 9/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 33/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 239/22 (2013.01 - EP US); C07D 239/70 (2013.01 - EP US); C07D 401/04 (2013.01 - EP US); C07D 405/04 (2013.01 - EP US); C07D 409/12 (2013.01 - EP US)
Citation (search report)
See references of WO 0232879A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0232879 A1 20020425; AU 5057001 A 20020429; CA 2426271 A1 20020425; EP 1326848 A1 20030716; JP 2004511549 A 20040415; US 2004024000 A1 20040205
DOCDB simple family (application)
IB 0100707 W 20010430; AU 5057001 A 20010430; CA 2426271 A 20010430; EP 01923889 A 20010430; JP 2002536262 A 20010430; US 39893803 A 20030411